-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprea Therapeutics Q1 EPS $(0.66) Up From $(0.67) YoY, Sales $162.46K Down From $380.57K YoY

Benzinga·05/14/2025 12:14:08
Listen to the news
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.66) per share. This is a 1.49 percent increase over losses of $(0.67) per share from the same period last year. The company reported $162.46 thousand in sales this quarter. This is a 57.31 percent decrease over sales of $380.57 thousand the same period last year.